German Flagship Project Annual Meeting: Building an End-to-End Clinical Platform for Quantum-Enhanced Metabolic MRI

ULM, Germany—We officially kicked-off the Q-AID project with the first in-person meeting between the research partners from IBEC, University of Antwerp and our industry AI teams from Gemelli Biotech, Aarhus University, DPU and CEA.

Q-AID’s mission is to integrate quantum-enhanced hyperpolarized MRI imaging with advanced AI, opening new possibilities for diagnosis and treatment of cancer, Alzheimer’s disease, and multiple sclerosis.

As part of the European Commission’s Quantum Europe Strategy, Q-AID helps to position Europe as a global leader in quantum innovation.

Learn more about Q-AID ↗

BRUSSELS, Belgium— The European Commission has formalized its Quantum Europe Strategy, listing Quantum-Enhanced MRI (Q-MRI) as a core priority for global leadership by 2030.

NVision's POLARIS platform provides the necessary room-temperature hyperpolarization technology to enable Q-MRI to be technically feasible and scalable in clinical settings. The alignment of POLARIS with this strategic mandate contributes to providing non-invasive, real-time metabolic insights as a "Made in Europe" quantum solution for global health.

Learn more ↗